Clinical Trials Search Tool

An Observational Study of Aducanumab-avwa in Participants With Alzheimer’s Disease in the US

Disease/Condition: Alzheimer’s disease

Location: Portland

Ages: 18+

Enrollment Opens: 01-01-2022

Enrollment Closes: TBD

Description:

This trial is part of the ICARE AD trio of trials, testing the safety and efficacy of Aduhelm in clinical practice. Participants will be followed up to 5 years after enrollment and data will be collected at routine visits every 6-12 months. This trial is sponsored by Biogen. For more information, please visit https://www.investors.biogen.com/news-releases/news-release-details/biogen-and-eisai-announce-design-aduhelm-icare-ad-us-study-first

Study ID: US-ALZ-11855

To Enroll: Call 503-476-9788 or schedule your free over-the-phone memory screen here: https://www.centerforcognitivehealth.com/resources/free-memory-screens/

Posted by: Center for Cognitive Health | https://www.centerforcognitivehealth.com/clinicaltrials/